top of page

​Symposium
“Precision Oncology & Artificial Intelligence”

Date and Venue

November 30, 2026

Tel Aviv, Israel

​​​​​​

As oncology moves towards increasingly personalized care, advances in artificial intelligence are opening up new possibilities to better characterize each cancer, refine diagnosis, and guide treatment according to each patient’s individual profile.

​

The Fondation France-Israël is organizing a French-Israeli symposium in Tel Aviv dedicated to Precision Oncology & Artificial Intelligence, bringing together researchers, physicians, and experts from leading scientific and medical institutions in both countries.

 

From personalized oncology to digital pathology, the symposium will provide an opportunity to share advances and practices and foster new collaborations around a common goal: harnessing artificial intelligence to advance increasingly precise and personalized cancer care.

​

This symposium will be held in English.

​​

To register, please contact Muriel Haim at the following address: muriel.haim@gmail.com

​​​

Médecin analysant des imageries médicales.png

Preliminary Program

​​​​​​​​​

​​​​​​​

08:30 — Registration & Welcome

​

09:00–09:30 — Opening Remarks

  • French Ambassador

  • MOST

 

09:30–10:00 — Keynote

  • Prof. Raanan Berger — Sheba Medical Center

​

10:00–12:00 — “Oncology in the Age of AI: One Patient, One Signature, One Treatment”

Personalized Oncology — using machine learning to combine genomics, medical records, imaging, and pathology

 

Israel

  • Prof. Keren Yitzhak — Technion

  • Prof. Dov Hershkovitz — Ichilov

  • Prof. Ron Kimmel — Technion

  • Prof. Leo Joskowicz — Hebrew University

France

  • Dr. Emmanuel Bacry — Health Data Hub

  • Prof. Elisabeth Moyal — Hospitalo-universitaire / University teacher hospital practitioner, CRCT – Oncopole

 

12:30–13:30 — Lunch

 

13:30–15:00 — “Digital Pathology: AI Under the Microscope”

Digital Pathology — analyzing pathology slides using AI to predict genetic mutations and response to treatment, without the need for expensive and slow genetic sequencing

 

Israel

  • Prof. Iris Barshack — Sheba Medical Center

  • Dr. Assaf Zaritsky — Ben Gurion University

 

France

  • Prof. Pierre Brousset — CHU Toulouse, Oncopole

  • Prof. Cécile Badoual — Gustave Roussy Hospital

 

15:00–15:15 — Closing Remarks

​

​

bottom of page